Kancera is a clinical stage biotech developing a new class of small molecule drugs with an immune cell modulating mode-of-action with focus on cardiovascular diseases. The lead program KAND567 is in clinical phase II-stage and is aiming to prevent reperfusion injury that may occur in connection with percutaneous coronary intervention in acute myocardial infarction. The stock is traded on the Nasdaq First North Premier Growth Market.
| Website | http://www.kancera.com |
| Ticker | KAN |
| Revenue | $40000 |
| Employees | 8 (8 on RocketReach) |
| Founded | 2010 |
| Address | 22 Banvaktsvägen, Solna, 26 171 48, SE |
| Phone | +46 8 501 260 80 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Manufacturing General, Pharmaceutical Manufacturing, Manufacturing, Science and Engineering, Pharmaceuticals |
| Keywords | Small Molecule Drugs, Biotechnology, Drug Development, Drug Discovery, Pharmaceutical, Oncology, Cancer Treatment, Immunology, Cancer Research, Therapeutics, Cancer Therapies, Immune System, Molecular Medicine, Precision Medicine, Biotech, Clinical Trials, Innovative Therapies |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, AbbVie, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Kancera employee's phone or email?
Kancera Questions
The Kancera annual revenue was $40000 in 2026.
Thomas Olin is the CEO of Kancera.
8 people are employed at Kancera.
Kancera is based in Solna, 26.
The NAICS codes for Kancera are [32541, 325, 32, 3254].
The SIC codes for Kancera are [283, 28].
Top Kancera Employees
-
Thomas Olin
CEO at Kancera
Solna, SE23 -
Johan Schultz
Project Director at Kancera
Stockholm, SE21 -
3
-
Peter Selin
Executive Vice President Corporate Development at Kancera
Stockholm, Stockholms Lan, Sweden1 -
Jan Vågberg
Project Team Leader at Kancera
Stockholm, SE1 -
Torbjörn Lundström
Chief Medical Officer at Kancera
Kungsbacka, SE1
Related Companies
